- Filed
- Apr 8, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Mar 31, 2025 | 12.99M sh |
| Cash And Equivalents | Q2 2025 · Feb 28, 2025 | $40.39M |
| Cash And Equivalents | Q2 2025 · Aug 31, 2024 | $48.66M |
| Stockholders Equity | Q2 2025 · Feb 28, 2025 | $72.53M |
| Stockholders Equity | Q2 2025 · Aug 31, 2024 | $83.14M |
| Current Liabilities | Q2 2025 · Feb 28, 2025 | $134.08M |
| Current Liabilities | Q2 2025 · Aug 31, 2024 | $162.45M |
| Total Liabilities | Q2 2025 · Feb 28, 2025 | $148.81M |
| Total Liabilities | Q2 2025 · Aug 31, 2024 | $178.4M |
| Current Assets | Q2 2025 · Feb 28, 2025 | $121.04M |
| Current Assets | Q2 2025 · Aug 31, 2024 | $160.25M |
| Total Assets | Q2 2025 · Feb 28, 2025 | $221.34M |
| Total Assets | Q2 2025 · Aug 31, 2024 | $261.54M |
| Shares Diluted | Q2 2025 · Feb 29, 2024 | 13.48M sh |
| Shares Diluted | Q2 2025 · Feb 29, 2024 | 13.56M sh |
| Stock Repurchased | Q2 2025 · Feb 29, 2024 | $18.41M |
| Capex | Q2 2025 · Feb 29, 2024 | $1.72M |
| Operating Cash Flow | Q2 2025 · Feb 29, 2024 | $30.21M |
| Eps Diluted | Q2 2025 · Feb 29, 2024 | $0.06 |
| Eps Diluted | Q2 2025 · Feb 29, 2024 | $0.42 |
| Eps Basic | Q2 2025 · Feb 29, 2024 | $0.07 |
| Eps Basic | Q2 2025 · Feb 29, 2024 | $0.43 |
| Sga Expense | Q2 2025 · Feb 29, 2024 | $40.77M |
| Sga Expense | Q2 2025 · Feb 29, 2024 | $84.98M |
| Net Income | Q2 2025 · Feb 29, 2024 | $874K |
| Net Income | Q2 2025 · Feb 29, 2024 | $5.73M |
| Operating Income | Q2 2025 · Feb 29, 2024 | $1.44M |
| Operating Income | Q2 2025 · Feb 29, 2024 | $6.77M |
| Gross Profit | Q2 2025 · Feb 29, 2024 | $46.85M |
| Gross Profit | Q2 2025 · Feb 29, 2024 | $99.13M |
| Cost Of Revenue | Q2 2025 · Feb 29, 2024 | $14.49M |
| Cost Of Revenue | Q2 2025 · Feb 29, 2024 | $30.61M |
| Revenue | Q2 2025 · Feb 29, 2024 | $61.34M |
| Revenue | Q2 2025 · Feb 29, 2024 | $129.74M |